Diagnostic clarification can be a separate outpatient episode
When MOGAD is uncertain, the center may need to review or repeat MOG-IgG testing, assess AQP4-IgG, review MRI and extend CSF or neuro-ophthalmological testing. Ask which external records can be reviewed before travel and which tests would need to be repeated in Germany.
- Neuroimmunology consultation
- MOG-IgG testing with specialist interpretation
- AQP4-IgG testing when required
- Brain, orbital and spinal-cord MRI as clinically indicated
- CSF examination
- OCT, visual testing or electrophysiology in selected optic-neuritis cases
Acute relapse care can require hospital-level resources
A significant attack can require high-dose intravenous corticosteroids, repeated neurological or visual assessment and, when response is inadequate or severity warrants it, an apheresis procedure. That cost cannot be meaningfully compared with an elective diagnostic second opinion.
Apheresis should be quoted as its own treatment episode
Blood-wash treatment can require vascular access, several sessions, laboratory monitoring and inpatient or day-unit resources. If apheresis is expected, request an episode-specific estimate and ask whether all planned sessions and associated hospital charges are included.
Long-term preventive therapy depends on relapse pattern
Some MOGAD patients may remain monophasic, while others relapse and require long-term immunotherapy. The ongoing budget can therefore range from follow-up only to repeated high-cost immunotherapy and monitoring. A center should first determine whether preventive treatment is justified for the individual disease course.
Monitoring continues beyond the first German visit
Patients receiving immunotherapy may need regular blood tests, infection-risk monitoring, neurological assessment and periodic imaging. Clarify which parts of this follow-up can be transferred to the patient's neurologist or ophthalmologist at home.
Incorrect classification can create an incorrect cost plan
MOGAD, AQP4-NMOSD and multiple sclerosis are distinct treatment pathways. A generic quotation for 'demyelinating disease' is less useful than an estimate linked to the final specialist diagnosis, attack history and treatment goal.
Send complete records before requesting a quotation
The hospital can estimate more accurately when the diagnostic evidence and relapse history are available before travel.
- Neurology and neuroimmunology reports
- MOG-IgG and AQP4-IgG results
- MRI images and reports
- CSF results
- OCT and other visual testing if optic neuritis occurred
- Previous steroid and apheresis treatment
- Current and previous preventive immunotherapy
- The purpose of the inquiry: diagnosis review, post-relapse review or long-term treatment planning
Official sources
Last source-reviewed 2026-09-01. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.